title: Serum adiponectin concentration prior to clinical onset of preeclampsia.
abstract: OBJECTIVE
  This study assesses whether the adipokine adiponectin is a useful marker in pregnant women who subsequently develop preeclampsia (PE).
  
  
  METHODS
  A retrospective case-control study was conducted to measure the total serum levels of adiponectin, measured by radioimmunoassay kit, in serum samples stored in serological biobanks.
  
  
  RESULTS
  Total serum adiponectin concentrations between the groups were not significantly different (p = 0.22). There were no obvious clinical signs of the preeclamptic inflammatory process at the time when samples were drawn.
  
  
  CONCLUSIONS
  Using this design, total adiponectin appeared not be a useful pre-clinical marker of PE.
authors.affiliation: Department of Gynaecology and Obstetrics, Rikshospitalet-Radiumhospitalet Medical Center, Oslo, Norway. nancy.odden@rikshospitalet.no
authors.forename: Nancy
authors.initials: N
authors.lastname: Odden
authors.forename: Tore
authors.initials: T
authors.lastname: Henriksen
authors.forename: Ellen
authors.initials: E
authors.lastname: Holter
authors.forename: Anne
authors.initials: A
authors.lastname: Grete Skar
authors.forename: Trygve
authors.initials: T
authors.lastname: Tjade
authors.forename: Lars
authors.initials: L
authors.lastname: Mørkrid
mesh_terms: D052242:Adiponectin / Q000097:blood*; D000328:Adult; D015415:Biomarkers / Q000097:blood; D001771:Blood Banks; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D011225:Pre-Eclampsia / Q000097:blood*; D011247:Pregnancy; D012189:Retrospective Studies; D012307:Risk Factors
chemical_list: D052242:Adiponectin; D015415:Biomarkers